申请人:Merrell Pharmaceuticals, Inc.
公开号:US05719193A1
公开(公告)日:1998-02-17
This invention relates to a method of potentiating cell-mediated immunity which comprises administering to a patient a cell-mediated immunity potentiating amount of a compound of the formula: RHN--Z--NH--(CH.sub.2).sub.m --NH--Z--NHR or a pharmaceutically acceptable salt thereof, wherein m is an integer 3 to 12, Z is a saturated C.sub.2 -C.sub.6 alkylene moiety of straight or branched chain configuration, each R group is independently H, a C.sub.1 -C.sub.6 saturated or unsaturated hydrocarbyl, or --(CH.sub.2).sub.x --(Ar)--X wherein X is H, C.sub.1 -C.sub.6 alkoxy, halogen, C.sub.1 -C.sub.4 alkyl, or --S(O).sub.x R.sub.1, x is an integer 0, 1 or 2, and R.sub.1 is C.sub.1 -C.sub.6 alkyl.
该发明涉及一种增强细胞介导免疫的方法,包括向患者给予一定量的化合物进行细胞介导免疫增强,该化合物的化学式为:RHN--Z--NH--(CH.sub.2).sub.m --NH--Z--NHR或其药用盐,其中m为整数3至12,Z为饱和的C.sub.2 -C.sub.6直链或支链构型的烷基部分,每个R基独立地为H,C.sub.1 -C.sub.6饱和或不饱和烃基,或--(CH.sub.2).sub.x --(Ar)--X,其中X为H,C.sub.1 -C.sub.6烷氧基,卤素,C.sub.1 -C.sub.4烷基,或--S(O).sub.x R.sub.1,x为整数0、1或2,R.sub.1为C.sub.1 -C.sub.6烷基。